How to submit a proposal
Translational Programmes
What funding schemes are available?
Wyeth-Funded Translational Programmes:
Collaborations between Wyeth and Scottish Investigators from participating institutions originate from publicised workshops designed to identify areas of common interest or from direct interaction with Wyeth Translational Scientists. Completed applications are submitted to TMRI. Scientific review of applications will be conducted by TMRC’s Scientific Review Board (SRB).
Non-Wyeth Funded Translational Programmes:
Additionally, where Wyeth does not provide funding for a translational program (funding provided by other non-commercial organizations, e.g.MRC), a Scottish Investigator in a participating institution may still access the resources of the TMRC, including the services of the TMRC Core Laboratory. Applications follow the same submission and review process as with Wyeth-Funded Translational Programmes.
Are collaborative projects encouraged?
Yes. The strength of the TMRC is based on collaboration across Scotland, engaging the universities, the NHS, scientists at the core laboratory and Wyeth Translational Medicine scientists. We believe focused workshops to be an ideal basis for productive collaborative research supporting the development of novel therapeutic agents. These workshops identify key translational issues in Wyeth Platforms and serve as a forum for discussion by a multidisciplinary group of scientists from several institutions.
What are the Intellectual Property (IP) arrangements for TMRC?
A key to the success of the TMRC is the timely and transparent respect of issues relating to the IP of all participants. IP that predates any collaboration (‘Background IP’) will remain the sole property of the contributing party. New IP (‘Foreground IP’) that results from TMRC collaborations will become the property of the TMRC, with the exception of IP relating to Wyeth drug candidates. Generally, Wyeth has the right to exploit foreground IP in the therapeutic field and the TMRI has the right to exploit the foreground IP in diagnostic and other fields. The four Scottish universities and NHS Boards are the shareholders and beneficiaries of any IP commercialisation through TMRI. Where background IP is required to exploit the IP outputs of a translational programme, it will generally be necessary for TMRI (via Scottish partners) and Wyeth to provide cross licenses to that IP. Royalty sharing arrangements are in place between Wyeth and TMRI, and TMRI and Universities/NHS partners. These arrangements provide a clear route for institutions and investigators to realise value from commercially useful project outputs.
Where can I find more information? With whom can I discuss my research ideas?
A good first point of contact for discussing research ideas are the Wyeth Translational Scientist(s). Please use the contact email link on this web site and a translational scientist will be in touch.
How do I apply ?
Once a proposal has been discussed with the translational scientists, please contact Yvonne Samson, TMRI Ltd, This e-mail address is being protected from spambots. You need JavaScript enabled to view it who will provide you with the necessary application forms, guidance notes, costing template and procedures to follow as well as a unique project code for your application. The application process will be facilitated by your university’s technology transfer office (TTO).